The Center for Drug Discovery is offering proof of concept pilot awards for Collaborative Drug Screening for Pediatric Diseases.
Eligibility: All Primary Faculties in the Department of Pediatrics, Emory University, and Children’s Healthcare of Atlanta
Application Deadline: February 20, 2018
Objectives: Pediatric Center for Drug Discovery (CDD) encourages basic and clinical researchers to submit applications that focus on using cell culture disease models for chemical library screening and drug discovery. CDD will provide $15,000 to selected applications proposing cellular phenotypic assays that are proper for the medium-throughput screening of the chemical libraries provided from CDD. Fluorescence-based cell imaging (i.e. GFP), enzyme based assays (i.e., luciferase), and cell counts (i.e. live and dead cells) are recommended as phenotypic readouts for the robotized drug screening instrument available in CDD (BioTek Cytation 3). Applicants should demonstrate the reliability, simplicity and reproducibility of the phenotypic readouts as well as disease relevance and significance. The long-term goal of this RFA is to enable the researchers to explore the drug discovery pathways for future translational and clinical applications.
Budget: $15,000 including salary and supplies
Decision Announcement: 3/1/2018 (The funds for the selected projects will be available immediately after the funding decision)
Date for the completion of the drug screening/data delivery and the end of the funding: 12/31/2018
Progress and Final Reports: Progress reports (maximum 4 pages) should be submitted by 8/1/2018, and the final report (maximum 5 pages) is due by 12/31/2018.
Additional Information:
* All applications should be submitted to Jennifer Villaseñor via email by 2/20/2018.
* Please email Dr. Baek Kim if you have any questions about this RFA.
